You are here: Industry Insights > Acquisition

News List

Aphena Acquires Konsyl Pharma Facility in Easton, MD contractpharma
March 24, 2020
Renovations and the installation of new equipment are underway, with plans to add an additional 100 jobs.
AbbVie, Allergan megamerger set for May close pharmatimes
March 23, 2020
AbbVie has released an update on its pending acquisition of Allergan, announcing that the companies have entered into a consent decree agreement with staff of the US Federal Trade Commission (FTC) regarding the deal.
European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius prnasia
March 20, 2020
The businesses to be acquired are part of Danaher's Life Sciences platform and include various laboratory and bioprocessing technologies that are complementary to the portfolios of both Sartorius divisions.
AcelRx to Acquire Tetraphase americanpharmaceuticalreview
March 19, 2020
AcelRx Pharmaceuticals announced a definitive merger agreement to acquire Tetraphase Pharmaceuticals in a stock for stock deal at an exchange ratio of 0.6303 shares of AcelRx ...
Bormioli Pharma to Acquire GCL Pharma for €8.9M contractpharma
March 19, 2020
Expands industrial footprint by adding new technologies to extend its oral and parenteral product range.
Bora Pharmaceuticals to Acquire GSK Mississauga-based Facility contractpharma
March 10, 2020
Bora Pharmaceuticals and GSK have entered into an agreement under which Bora will acquire GSK’s Mississauga, Ontario (Canada) facility.
Bactiguard Completes Acquisition of Vigilenz prnasia
March 03, 2020
Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020.
Merck closes $2.7bn acquisition of biopharmaceutical firm ArQule pharmaceutical-technology
January 19, 2020
Merck (MSD) has completed its previously announced acquisition of US-based biopharmaceutical company ArQule. The $2.7bn deal closed following completion of the cash tender offer that involved acquiring ArQule’s outstanding shares of common stock at $20 pe
WuXi Biologics to acquire drug manufacturing plant in Germany pharmaceutical-technology
January 19, 2020
WuXi Biologics has signed an acquisition agreement to take over a Bayer’s drug product manufacturing plant in Leverkusen, Germany. The Leverkusen plant will be the Chinese firm’s first drug product facility in Europe bolstering its commercial manufacturin
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany(1) PharmaSources/Wuxi Biologics
January 16, 2020
WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page